Trials / Active Not Recruiting
Active Not RecruitingNCT06708416
A Study of ONO-1110 in Patients With Postherpetic Neuralgia
A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Postherpetic Neuralgia
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-1110 | ONO-1110 tablets once a day |
| DRUG | Placebo | Placebo tablets once daily |
Timeline
- Start date
- 2025-02-12
- Primary completion
- 2026-06-30
- Completion
- 2026-08-31
- First posted
- 2024-11-27
- Last updated
- 2026-03-02
Locations
31 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT06708416. Inclusion in this directory is not an endorsement.